1. Home
  2. Tag "upgrades"

Analysts’ Varied Perspectives On CytomX’s CX-904 Cancer Study: Safety Profile But Caution in Pancreatic Cancer

Wednesday, CytomX Therapeutics Inc (NASDAQ:CTMX) released initial data from the ongoing CX-904 Phase 1a dose escalation clinical study, demonstrating a favorable safety profile and confirmed anti-cancer activity.  As of April 16, 2024, data cutoff, the Phase 1 study enrolled 35 heavily pretreated patients with advanced metastatic solid tumor types. CX-904 demonstrated a favorable safety profile, supporting administration and […]

SiTime Stock Skyrockets 30% After Analyst Upgrade

SiTime Corp (NASDAQ:SITM) shares are trading higher after Needham analyst Quinn Bolton upgraded the stock rating from Hold to Buy with a $130 price target. SiTime posted revenue of $33.0 million, down 13.9% year over year, but above Bolton’s estimate and the Street’s $32 million estimate, due to downward trends in customer inventories that resulted in a pickup in order activity. Only […]

EVgo’s Q1 Performance Sparks Optimism, Analyst Upgrades Stock

Cantor Fitzgerald analyst Andres Sheppard upgraded the shares of EVgo Inc (NASDAQ:EVGO) from Neutral to Overweight and lowered the price target from $5 to $4. EVGO reported a first-quarter FY24 sales jump of 118.2% year-on-year to $55.16 million, beating the analyst consensus estimate of $52.389 million. EPS of $(0.09) beat the analyst consensus estimate of $(0.14). EVgo also announced that Olga […]

What’s Going On With Micron Tech Stock On Monday?

Micron Technology Inc (NASDAQ:MU) shares are trading higher after Baird analyst Tristan Gerra upgraded the stock from Neutral to Outperform and raised its price target from $115 to $150. Citi analyst Christopher Danely remains bullish on the U.S. semiconductor sector. His top pick remains Micron Technology, Inc (NASDAQ:MU)  with other Buy-rated names, including Advanced Micro Devices, Inc (NASDAQ:AMD), Broadcom Inc (NASDAQ:AVGO), Analog Devices, Inc (NASDAQ:ADI), Microchip Technology Inc (NASDAQ:MCHP), and ON […]

Amgen Outlook Is Bright, Analyst Predict Obesity-Focused Drug Potential Will Drive Shareholder Value

Amgen Inc (NASDAQ:AMGN) reported first-quarter (Q1) earnings Thursday, touting adjusted EPS of $3.96, which beat the analyst consensus estimate of $3.87. Here are highlights from the release and subsequent analyst call: Sales increased 22% Y/Y to $7.45 billion, which beat the analyst consensus estimate of $7.436 billion. Amgen sees full-year 2024 adjusted EPS of $19-$20.20 versus consensus […]

MELI IS UP 121 DOLLARS EARNINGS BEAT PAYING US BIG

Try our free 5 day trial today https://turbooptiontrading.com/free-5-day-trial- • Earnings Per Share (EPS): The EPS was recorded at $6.78, which surpassed the analyst expectations of $6.031. • Total Payment Volume: The total payment volume grew by 35% year-over-year to $40.7 billion, indicating strong payment processing growth1. • Gross Merchandise Volume (GMV): The GMV increased by […]

Seagate Poised for Growth with Rising HDD Demand and Advanced HAMR Technology: Analyst

Wedbush analyst Matt Bryson upgraded Seagate Technology Holdings Inc (NASDAQ:STX) from Neutral to Outperform with a $100 price target. The re-rating reflected an improving nearline Hard Disk Drive (HDD) demand environment that creates a likely upside to Bryson’s near-term expectations and his increased conviction that Heat Assisted Magnetic Recording (HAMR) is a “good” technology, with the ramp of HAMR only likely to […]